September 2017
Centers for Disease Control and Prevention, Health and Human Services. Announcement: Final 2016–17 Influenza Vaccination Coverage Estimates Available Online MMWR. 2017;66(38);1028.
The online information includes estimates of the cumulative percentage of persons receiving influenza vaccination through the end of each month during July 2016–May 2017…- Ding H, Black CL, Ball S, Fink RV, Williams WW, Fiebelkorn AP, et al. Influenza Vaccination Coverage Among Pregnant Women — United States, 2016–17 Influenza Season MMWR. 2017;66(38);1016-22.
In this report, vaccination coverage was lower among pregnant women with public health insurance than among those with private or military insurance… - Black CL, Yue X, Ball SW, Fink R, de Perio MA, Laney AS et al. Influenza Vaccination Coverage Among Health Care Personnel — United States, 2016–17 Influenza Season MMWR. 2017;66(38);1009-15.
The Advisory Committee on Immunization Practices recommends all health care personnel receive an annual influenza vaccination… - Nelson NP. Updated Dosing Instructions for Immune Globulin (Human) GamaSTAN S/D for Hepatitis A Virus Prophylaxis MMWR. 2017;66(36);959-60.
In July 2017, GamaSTAN S/D prescribing information was updated with changes to the dosing instructions for hepatitis A preexposure and postexposure prophylaxis indications…
August 2017
- Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Bresee JS, Fry AM, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season MMWR. 2017;66(RR-2);1-20.
This report updates the 2016–17 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines (MMWR Recomm Rep 2016;65[No. RR-5])… - Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, et al. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2016 MMWR. 2017;66(33);874-82.
This report presents vaccination coverage estimates for 20,475 adolescents (9,661 females and 10,814 males) aged 13–17 years with adequate provider data… - Martinez M, Shukla H, Nikulin J, Wadood MZ, Hadler S, Mbaeyi C, et al. Progress Toward Poliomyelitis Eradication — Afghanistan, January 2016–June 2017 MMWR. 2017;66(32);854-8.
This report describes polio eradication activities, progress, and challenges in Afghanistan during January 2016–June 2017 and updates previous reports… - Aku FY, Lessa FC, Asiedu-Bekoe F, Balagumyetime P, Ofosu W, Farrar J, et al. Meningitis Outbreak Caused by Vaccine-Preventable Bacterial Pathogens — Northern Ghana, 2016 MMWR. 2017;66(30);806-10.
Rapid identification of the etiologic agent in meningitis outbreaks is important for informing targeted public health interventions…
July 2017
- Gershman MD, Sotir MJ. Update: Temporary Total Depletion of U.S. Licensed Yellow Fever Vaccine for Civilian Travelers Addressed by Investigational New Drug Use of Imported Stamaril Vaccine MMWR. 2017;66(29);780.
During the interim period until YF-VAX is available again for use in the United States, Stamaril will be available in a limited number of designated clinics, selected to provide access to vaccine in U.S. states and certain territories… - Le DP, Vega J, Johnson LA. Notes from the Field: Hospital Contact Investigation for a Patient Who Developed a Zoster Vaccine–Related Rash — Maryland, February 2015 MMWR. 2017;66(28);763-4.
This case highlights the importance of maintaining vigilance for unusual events following the use of live vaccines in persons who receive immunosuppressant medications, the importance of vaccination for primary prevention of communicable diseases in hospital settings, and the value of a robust occupational health program as a critical component of hospital infection control efforts… - Khanal S, Bohara R, Chacko S, Sharifuzzaman M, Shamsuzzaman M, Goodson JL, et al. Progress Toward Measles Elimination — Bangladesh, 2000–2016 MMWR. 2017;66(28);753-7.
This report describes progress and challenges toward measles elimination in Bangladesh during 2000–2016… - Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA). Announcement: Implementation of the Vaccine Adverse Event Reporting System 2.0 Reporting Form MMWR. 2017;66(27);738.
Transition to the VAERS 2.0 form is expected to be completed by the end of December 2017… - Black CL, Williams W, Warnock R, Pilishvili T, Kim D, Kelman JA. Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 Years MMWR. 2017;66(27);728-33.
Initiation and completion of the pneumococcal vaccination series among adults aged ≥65 years can be improved by implementation of the standards for adult immunization practice… - Hall V, Banerjee E, Kenyon C, Strain A, Griffith J, Como-Sabetti K, et al. Measles Outbreak — Minnesota April–May 2017 MMWR. 2017;66(27);713-7.
This outbreak demonstrates the challenge of combating misinformation about MMR vaccine and the importance of creating long-term, trusted relationships with communities to disseminate scientific information in a culturally appropriate and effective manner… - McNamara LA, Topaz N, Wang X, Hariri S, Fox L, MacNeil JR. High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine MMWR. 2017;66(27);734-7.
Heightened awareness, early care seeking, and rapid treatment of any symptoms consistent with meningococcal disease are essential for all patients receiving eculizumab treatment, regardless of meningococcal vaccination or antimicrobial prophylaxis status…
June 2017
- Blanton L, Alabi N, Mustaquim D, Taylor C, Kniss K, Kramer N, et al. Update: Influenza Activity in the United States During the 2016–17 Season and Composition of the 2017–18 Influenza Vaccine MMWR. 2017;66(25);668-76.
This report summarizes influenza activity in the United States during October 2, 2016–May 20, 2017 and updates the previous summary… - Previsani N, Singh H, St. Pierre J, Boualam L, Fournier-Caruana J, Sutter RW, et al. Progress Toward Containment of Poliovirus Type 2 — Worldwide, 2017 MMWR. 2017;66(24);649–52.
This report summarizes the current status of poliovirus containment and progress since the last report, and outlines remaining challenges… - Heffelfinger JD, Li X, Batmunkh N, Grabovac V, Diorditsa S, Liyanage JB, et al. Japanese Encephalitis Surveillance and Immunization — Asia and Western Pacific Regions, 2016 MMWR. 2017;66(22);579–83.
This report updates a previous summary of JE surveillance and immunization programs in Asia and the Western Pacific in 2012…
May 2017
- Patton ME, Stephens D, Moore K, MacNeil JR. Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016 MMWR. 2017;66(19);509-13.
These recommendations are regarding use of the 2- and 3-dose schedules of MenB-FHbp vaccine (Trumenba) and replace previous ACIP recommendations for use of MenB-FHbp vaccine published in 2015… - Venkat H, Kassem AM, Su C, Hill C, Timme E, Briggs G, et al. Notes from the Field: Measles Outbreak at a United States Immigration and Customs Enforcement Facility ― Arizona, May–June 2016 MMWR. 2017;66(20);543–4.
Recommendations for implementing measles control policies for detention and correctional facilities, similar to those recommended in health care facilities, could be considered… - Diop OM, Asghar H, Gavrilin E, Moeletsi NG, Benito GR, Paladin F, et al. Virologic Monitoring of Poliovirus Type 2 after Oral Poliovirus Vaccine Type 2 Withdrawal in April 2016 — Worldwide, 2016–2017 MMWR. 2017;66(20);538–42.
This report details for the first time the virologic tracking of elimination of a live vaccine that has been withdrawn from routine and mass immunization systems worldwide … - Wong KK, Burdette E, Mahon BE, Mintz ED, Ryan ET, Reingold AL. Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine MMWR. 2017;66(18);482-5.
This report provides new recommendations and guidance for vaccination providers and travelers about the use of lyophilized CVD 103-HgR… - Abara WE, Cha S, Malik T, DeSimone MS, Schumann B, Mallada E, et al. Hepatitis B Surface Antigen Screening Among Pregnant Women and Care of Infants of Hepatitis B Surface Antigen–Positive Mothers — Guam, 2014 MMWR. 2017;66(19);506-8.
Timely administration of PEP to infants of HBsAg-positive women is important to prevent perinatal HBV transmission… - Williams WW, Lu P, O’Halloran A, Kim DK, Grohskopf LA, Pilishvili T, et al. Surveillance of Vaccination Coverage Among Adult Populations — United States, 2015 MMWR. 2017;66(SS-11);1-28.
The estimates provided in this report can be used by public health practitioners, adult vaccination providers, and the general public to understand better the factors that contribute to low vaccination rates and modify strategies and interventions to improve vaccination coverage… - Gershman MD, Angelo KM, Ritchey J, Greenberg DP, Muhammad RD, Brunette G, et al. Addressing a Yellow Fever Vaccine Shortage — United States, 2016–2017 MMWR. 2017;66(17);457-9.
Providers need to be aware that there is a yellow fever vaccine shortage and there is a plan for providing safe vaccine at a limited number of clinics until the supply is replenished… - Masresha BG, Dixon MG, Kriss JL, Katsande R, Shibeshi ME, Luce R, et al. Progress Toward Measles Elimination — African Region, 2013–2016MMWR. 2017;66(17);436-43.
This report updates the previous report and describes progress toward measles elimination in AFR during 2013–2016…
April 2017
- Ellis M, Luna-Pinto C, George T, Regan JJ, Marin M, Lopez A, et al. Notes from the Field: Varicella Fatality on a Cargo Vessel — Puerto Rico, 2015MMWR. 2017;66(15);410.
This investigation highlights the importance of early notification of illness or death to CDC by ships arriving to U.S. ports of entry, and the use of CDC’s varicella management guidance to prevent further transmission (6), including surveillance for febrile rash illness, isolation of cases, screening for varicella immunity, and vaccination of nonimmune persons… - Qualls N, Levitt A, Kanade N, Wright-Jegede N, Dopson S, Biggerstaff M, et al. Community Mitigation Guidelines to Prevent Pandemic Influenza — United States, 2017 MMWR. 2017;66(RR-1);1-34.
This report provides a brief introduction to pandemic influenza and NPIs; describes the 2007 strategy and the purpose of the updates, particularly after the 2009 H1N1 pandemic; outlines the methods used to develop this update and describe the evidence considered for NPI use during an influenza pandemic; presents CDC’s NPI recommendations; and discusses key areas for further NPI research… - Donahue M, Schneider A, Ukegbu U, Shah M, Riley J, Weigel A, et al. Notes from the Field: Complications of Mumps During a University Outbreak Among Students Who Had Received 2 Doses of Measles-Mumps-Rubella Vaccine — Iowa, July 2015–May 2016 MMWR. 2017;66(14);390-1.
this case series demonstrates that complications still occur, even in persons who have received the recommended 2 doses of measles-mumps-rubella vaccine… - Maes EF, Diop OM, Jorba J, Chavan S, Tangermann RH, Wassilak SGF. Surveillance Systems to Track Progress Toward Polio Eradication — Worldwide, 2015–2016 MMWR. 2017;66(13);359-65.
This report presents poliovirus surveillance data from 2015 and 2016, with particular focus on 20 countries in the African Region and six in the Eastern Mediterranean Region that reported WPV or circulating VDPVs (cVDPVs) during 2011–2016, as well as the three countries most affected by the 2014–2015 Ebola virus disease (Ebola) outbreak (Guinea, Liberia, and Sierra Leone)…
March 2017
- Otshudiema JO, Ndakala NG, Loko ML, Mawanda EK, Tshapenda GP, Kimfuta JM, et al. Notes from the Field: Adverse Events Following a Mass Yellow Fever Immunization Campaign — Kongo Central Province, Democratic Republic of the Congo, September 2016 MMWR. 2017;66(12);343-4.
AEFIs identified through this comprehensive review were compared with those detected through passive surveillance during the immunization campaign to assess the completeness and representativeness of passive surveillance data… - Otshudiema JO, Ndakala NG, Mawanda EK, Tshapenda GP, Kimfuta JM, Nsibu LN, et al. Yellow Fever Outbreak — Kongo Central Province, Democratic Republic of the Congo, August 2016 MMWR. 2017;66(12);335-8.
Strategies to improve coordination between health surveillance and cross-border trade activities at land borders and to enhance laboratory and case-based surveillance and health border screening capacity are needed to prevent and control future yellow fever outbreaks… - Yaffee AQ, Day DL, Bastin G, Powell M, Melendez S; Allen N, et al. Notes from the Field: Obstetric Tetanus in an Unvaccinated Woman After a Home Birth Delivery — Kentucky, 2016 MMWR. 2017;66(11);307-8.
This case highlights the importance of tetanus vaccination for all persons as recommended by ACIP… - Boyd AT, Dombaxe D, Moreira R, Oliveira MS, Manuel E, Colorado CN, et al. Notes from the Field: Investigation of Patients Testing Positive for Yellow Fever Viral RNA After Vaccination During a Mass Yellow Fever Vaccination Campaign — Angola, 2016 MMWR. 2017;66(10);282-3.
CDC and the Angola Field Epidemiology and Laboratory Training Program conducted an investigation of patients with a history of yellow fever vaccination and symptoms of yellow fever disease whose specimens tested positive for yellow fever viral RNA by reverse transcription–polymerase chain reaction (RT-PCR) to assess whether such cases could represent vaccine failure or AEFIs… - Iuliano AD, Jang Y, Jones J, Davis CT, Wentworth DE, Uyeki TM, et al. Increase in Human Infections with Avian Influenza A(H7N9) Virus During the Fifth Epidemic — China, October 2016–February 2017 MMWR. 2017;66(9);254-5.
Candidate vaccine viruses (CVVs) were developed, and vaccine was manufactured based on representative viruses detected after the emergence of A(H7N9) virus in humans in 2013… - Mbaeyi C, Ryan MJ, Smith P, Mahamud A, Farag N, Haithami S, et al. Response to a Large Polio Outbreak in a Setting of Conflict — Middle East, 2013–2015 MMWR. 2017;66(8);227–31.
Countries experiencing active conflict and chronic insecurity are at increased risk for polio outbreaks because of political instability and population displacement hindering delivery of immunization services…
February 2017
- Nnadi C, Damisa E, Esapa L, Braka F, Waziri N, Siddique A, et al. Continued Endemic Wild Poliovirus Transmission in Security-Compromised Areas — Nigeria, 2016 MMWR. 2017;66(7);190-3.
Increasing polio vaccination coverage and implementing high-quality polio surveillance, especially among populations in newly secured and difficult-to-access areas in Borno and other Lake Chad basin areas are urgently needed… - Flannery B, Chung JR, Thaker SN, Monto AS, Martin ET, Belongia EA, et al. Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness — United States, February 2017 MMWR. 2017;66(6);167-71.
This report uses data, as of February 4, 2017, from 3,144 children and adults enrolled in the U.S. Influenza Vaccine Effectiveness Network (U.S. Flu VE Network) during November 28, 2016–February 4, 2017, to estimate an interim adjusted effectiveness of seasonal influenza vaccine for preventing laboratory-confirmed influenza virus infection associated with medically attended ARI… - Blanton L, Mustaquim D, Alabi N, Kniss K, Kramer1 N, Budd A, et al. Update: Influenza Activity — United States, October 2, 2016–February 4, 2017 MMWR. 2017;66(6);159-66.
This report summarizes U.S. influenza activity during October 2, 2016–February 4, 2017, and updates the previous summary… - Kim DK, Riley LE, Harriman KH, Hunter P, Bridges CB. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2017 MMWR. 2017;66(5);136-8.
The 2017 adult immunization schedule summarizes ACIP recommendations in two figures, footnotes for the figures, and a table of contraindications and precautions for vaccines recommended for adults… - Robinson CL, Romero JR, Kempe A, Pellegrini C; Advisory Committee on Immunization Practices (ACIP) Child/Adolescent Immunization Work Group. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2017 MMWR. 2017;66(5);134-5.
The 2017 child and adolescent immunization schedule summarizes ACIP recommendations, including several changes from the 2016 immunization schedules, in three figures, and footnotes for the figures… - Marlow MA, Chitula MA; Francisco C, Conceiçao O, Soares MJ, Silva S, et al. Notes from the Field: Knowledge, Attitudes, and Practices Regarding Yellow Fever Vaccination Among Men During an Outbreak — Luanda, Angola, 2016 MMWR. 2017;66(4);117-8.
Increased availability of clear information and adaptation of the vaccination activities to the target population’s daily activities were needed…
January 2017
- Barber A, Muscoplat MH, Fedorowicz A. Coverage with Tetanus, Diphtheria, and Acellular Pertussis Vaccine and Influenza Vaccine Among Pregnant Women — Minnesota, March 2013–December 2014 MMWR. 2017;66(02);56-9.
Measures are needed to improve adequacy of prenatal care and reduce health disparities among minority, poor, and non–U.S.-born women to address maternal vaccination disparities… - Marin M, Patel M, Oberste S, Pallansch MA. Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States MMWR. 2017;66(01);23-5.
This report summarizes current Advisory Committee on Immunization Practices (ACIP) recommendations for poliovirus vaccination and provides CDC guidance, in the context of the switch from tOPV to bOPV, regarding assessment of vaccination status and vaccination of children who might have received poliovirus vaccine outside the United States, to ensure that children living in the United States (including immigrants and refugees) are protected against all three poliovirus types… - Bahl S, Hampton LM, Bhatnagar P, Rao GS, Haldar P, Sangal L, et al. Notes from the Field: Detection of Sabin-Like Type 2 Poliovirus from Sewage After Global Cessation of Trivalent Oral Poliovirus Vaccine — Hyderabad and Ahmedabad, India, August–September 2016 MMWR. 2017;65(52);1493–4.
This investigation underscores the importance of maintaining robust surveillance for polioviruses and of immunization workers being alert for tOPV vials in cold chain storage and reporting any tOPV vials that they find…
.png)
No hay comentarios:
Publicar un comentario